KR102103021B1 - 편백 추출물을 함유하는 항아토피 및 항질염용 티슈 및 이의 제조방법 - Google Patents
편백 추출물을 함유하는 항아토피 및 항질염용 티슈 및 이의 제조방법 Download PDFInfo
- Publication number
- KR102103021B1 KR102103021B1 KR1020190073045A KR20190073045A KR102103021B1 KR 102103021 B1 KR102103021 B1 KR 102103021B1 KR 1020190073045 A KR1020190073045 A KR 1020190073045A KR 20190073045 A KR20190073045 A KR 20190073045A KR 102103021 B1 KR102103021 B1 KR 102103021B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- tissue
- weight
- parts
- cypress
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000284 extract Substances 0.000 title claims abstract description 139
- 238000000034 method Methods 0.000 title claims abstract description 9
- 238000002360 preparation method Methods 0.000 title description 9
- 241000218691 Cupressaceae Species 0.000 claims abstract description 39
- 206010003645 Atopy Diseases 0.000 claims abstract description 29
- 230000003110 anti-inflammatory effect Effects 0.000 claims abstract description 28
- 238000004519 manufacturing process Methods 0.000 claims abstract description 15
- 235000003805 Musa ABB Group Nutrition 0.000 claims description 22
- 235000015266 Plantago major Nutrition 0.000 claims description 22
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 20
- 241000018646 Pinus brutia Species 0.000 claims description 20
- 235000011613 Pinus brutia Nutrition 0.000 claims description 20
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 19
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 19
- 241001330002 Bambuseae Species 0.000 claims description 19
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 19
- 239000011425 bamboo Substances 0.000 claims description 19
- 206010046914 Vaginal infection Diseases 0.000 claims description 18
- 235000011347 Moringa oleifera Nutrition 0.000 claims description 17
- 201000008100 Vaginitis Diseases 0.000 claims description 17
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 16
- 240000006891 Artemisia vulgaris Species 0.000 claims description 16
- 239000004744 fabric Substances 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 241000167550 Centella Species 0.000 claims description 13
- 239000012153 distilled water Substances 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 9
- 208000004926 Bacterial Vaginosis Diseases 0.000 claims description 8
- 208000037009 Vaginitis bacterial Diseases 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 208000003251 Pruritus Diseases 0.000 claims description 3
- 230000007803 itching Effects 0.000 claims description 3
- 244000179886 Moringa oleifera Species 0.000 claims 4
- 240000008790 Musa x paradisiaca Species 0.000 claims 4
- 239000001522 artemisia absinthium l. herb extract Substances 0.000 claims 2
- 229940119569 wormwood extract Drugs 0.000 claims 2
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 28
- 239000000126 substance Substances 0.000 abstract description 11
- 241000191967 Staphylococcus aureus Species 0.000 abstract description 10
- 241000222122 Candida albicans Species 0.000 abstract description 9
- 229940095731 candida albicans Drugs 0.000 abstract description 8
- 241000588724 Escherichia coli Species 0.000 abstract description 6
- 241000191963 Staphylococcus epidermidis Species 0.000 abstract description 6
- 241000186427 Cutibacterium acnes Species 0.000 abstract description 5
- 229940055019 propionibacterium acne Drugs 0.000 abstract description 5
- 229920002994 synthetic fiber Polymers 0.000 abstract description 3
- 210000001519 tissue Anatomy 0.000 description 70
- 230000000052 comparative effect Effects 0.000 description 41
- 240000005561 Musa balbisiana Species 0.000 description 17
- 210000003491 skin Anatomy 0.000 description 17
- 210000004027 cell Anatomy 0.000 description 15
- 241000894006 Bacteria Species 0.000 description 13
- 241000220215 Moringa Species 0.000 description 13
- 239000002609 medium Substances 0.000 description 12
- 238000012360 testing method Methods 0.000 description 11
- 239000000203 mixture Substances 0.000 description 9
- 210000001215 vagina Anatomy 0.000 description 9
- 201000004624 Dermatitis Diseases 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 210000002374 sebum Anatomy 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 244000301850 Cupressus sempervirens Species 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 230000028327 secretion Effects 0.000 description 6
- 102100021943 C-C motif chemokine 2 Human genes 0.000 description 5
- 101710155857 C-C motif chemokine 2 Proteins 0.000 description 5
- 241000207201 Gardnerella vaginalis Species 0.000 description 5
- 108090001005 Interleukin-6 Proteins 0.000 description 5
- 108090001007 Interleukin-8 Proteins 0.000 description 5
- 206010040880 Skin irritation Diseases 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 238000009792 diffusion process Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 230000036556 skin irritation Effects 0.000 description 5
- 231100000475 skin irritation Toxicity 0.000 description 5
- 239000000341 volatile oil Substances 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 3
- 241000241413 Propolis Species 0.000 description 3
- 244000178231 Rosmarinus officinalis Species 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 239000004599 antimicrobial Substances 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 229940094952 green tea extract Drugs 0.000 description 3
- 235000020688 green tea extract Nutrition 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 229940069949 propolis Drugs 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 235000005638 Austrian pine Nutrition 0.000 description 2
- 244000075850 Avena orientalis Species 0.000 description 2
- 235000007319 Avena orientalis Nutrition 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 206010012438 Dermatitis atopic Diseases 0.000 description 2
- 241000207202 Gardnerella Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 241000282376 Panthera tigris Species 0.000 description 2
- 235000008565 Pinus banksiana Nutrition 0.000 description 2
- 244000019397 Pinus jeffreyi Species 0.000 description 2
- 235000013264 Pinus jeffreyi Nutrition 0.000 description 2
- 235000008578 Pinus strobus Nutrition 0.000 description 2
- 235000008585 Pinus thunbergii Nutrition 0.000 description 2
- 235000014030 Podocarpus spicatus Nutrition 0.000 description 2
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 2
- 229920001131 Pulp (paper) Polymers 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 201000008937 atopic dermatitis Diseases 0.000 description 2
- 230000003749 cleanliness Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 210000004513 dentition Anatomy 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 231100000676 disease causative agent Toxicity 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229910052732 germanium Inorganic materials 0.000 description 2
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 2
- 230000009422 growth inhibiting effect Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 235000017985 rocky mountain lodgepole pine Nutrition 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 230000036346 tooth eruption Effects 0.000 description 2
- 239000001974 tryptic soy broth Substances 0.000 description 2
- 108010050327 trypticase-soy broth Proteins 0.000 description 2
- 210000003905 vulva Anatomy 0.000 description 2
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 description 1
- JQMFQLVAJGZSQS-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JQMFQLVAJGZSQS-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- 240000005020 Acaciella glauca Species 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000020154 Acnes Diseases 0.000 description 1
- 206010000871 Acute monocytic leukaemia Diseases 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 206010060937 Amniotic cavity infection Diseases 0.000 description 1
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 208000004746 Atrophic Vaginitis Diseases 0.000 description 1
- 206010003693 Atrophic vulvovaginitis Diseases 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 240000007436 Cananga odorata Species 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 208000008158 Chorioamnionitis Diseases 0.000 description 1
- 241000238586 Cirripedia Species 0.000 description 1
- 241001112695 Clostridiales Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241001573881 Corolla Species 0.000 description 1
- 235000018782 Dacrydium cupressinum Nutrition 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 208000004145 Endometritis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 241001316290 Gypsophila Species 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000004429 Matricaria chamomilla var recutita Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000025370 Middle East respiratory syndrome Diseases 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 208000035489 Monocytic Acute Leukemia Diseases 0.000 description 1
- 241000234295 Musa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 235000013697 Pinus resinosa Nutrition 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 241000263249 Plantago elongata Species 0.000 description 1
- 206010036600 Premature labour Diseases 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 235000014220 Rhus chinensis Nutrition 0.000 description 1
- 240000003152 Rhus chinensis Species 0.000 description 1
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 240000003294 Thysanolaena latifolia Species 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 229960003942 amphotericin b Drugs 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000002686 anti-diuretic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 235000020230 cinnamon extract Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 229940124558 contraceptive agent Drugs 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- -1 fractions Substances 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 229940065115 grapefruit extract Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- VHVPQPYKVGDNFY-ZPGVKDDISA-N itraconazole Chemical compound O=C1N(C(C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-ZPGVKDDISA-N 0.000 description 1
- 229960004130 itraconazole Drugs 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229940062713 mite extract Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- VOFUROIFQGPCGE-UHFFFAOYSA-N nile red Chemical compound C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4OC3=CC(=O)C2=C1 VOFUROIFQGPCGE-UHFFFAOYSA-N 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 244000039328 opportunistic pathogen Species 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 201000010808 postmenopausal atrophic vaginitis Diseases 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000026440 premature labor Diseases 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012449 sabouraud dextrose agar Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000004378 sebocyte Anatomy 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000004071 soot Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
- A45D44/00—Other cosmetic or toiletry articles, e.g. for hairdressers' rooms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
- A61K8/9761—Cupressaceae [Cypress family], e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
- A45D2200/00—Details not otherwise provided for in A45D
- A45D2200/10—Details of applicators
- A45D2200/1009—Applicators comprising a pad, tissue, sponge, or the like
- A45D2200/1027—Tissues, i.e. thin applicator sheets
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
Description
도 1은 본 발명에 따라 제조된 티슈 처리 후 피지분비 억제 정도를 보여주는 것이다.
편백 추출물 | 쑥 추출물 | 모링가 추출물 | 대나무 추출물 | 병풀 추출물 | 소나무 추출물 | 질경이 추출물 | |
실시예 1 | 30 중량부 | - | - | - | - | - | - |
실시예 2 | 30 중량부 | 12 중량부 | - | - | - | - | - |
실시예 3 | 30 중량부 | - | 12 중량부 | - | - | - | - |
실시예 4 | 30 중량부 | - | - | 12 중량부 | - | - | - |
실시예 5 | 30 중량부 | - | - | - | 12 중량부 | - | - |
실시예 6 | 30 중량부 | - | - | - | - | 12 중량부 | - |
실시예 7 | 30 중량부 | - | - | - | - | - | 12 중량부 |
실시예 8 | 30 중량부 | 2 중량부 |
2 중량부 |
2 중량부 |
2 중량부 |
2 중량부 |
2 중량부 |
비교예 1 | - | - | - | - | - | - | - |
비교예 2 | - | 30 중량부 | - | - | - | - | - |
비교예 3 | - | - | 30 중량부 | - | - | - | - |
비교예 4 | - | - | - | 30 중량부 | - | - | - |
비교예 5 | - | - | - | - | 30 중량부 | - | - |
비교예 6 | - | - | - | - | - | 30 중량부 | - |
비교예 7 | - | - | - | - | - | 30 중량부 |
Escherichia coli | Staphylococcus epidermidis | Staphylococcus aureus | Propionibacterium acnes | |
실시예 1 | ++ | ++ | ++ | ++ |
실시예 2 | ++ | ++ | ++ | ++ |
실시예 3 | ++ | ++ | ++ | ++ |
실시예 4 | ++ | ++ | ++ | ++ |
실시예 5 | ++ | ++ | ++ | ++ |
실시예 6 | ++ | ++ | ++ | ++ |
실시예 7 | ++ | ++ | ++ | ++ |
실시예 8 | ++ | ++ | ++ | ++ |
비교예 1 | - | - | - | - |
비교예 2 | -+ | -+ | -+ | -+ |
비교예 3 | -+ | -+ | -+ | -+ |
비교예 4 | -+ | -+ | -+ | -+ |
비교예 5 | -+ | -+ | -+ | -+ |
비교예 6 | -+ | -+ | -+ | -+ |
비교예 7 | -+ | -+ | -+ | -+ |
MCP-1 | IL-6 | IL-8 | |
진드기 추출물 | 1.00 | 1.00 | 1.00 |
실시예 1 | 0.21 | 0.22 | 0.23 |
실시예 2 | 0.17 | 0.20 | 0.19 |
실시예 3 | 0.20 | 0.18 | 0.17 |
실시예 4 | 0.19 | 0.17 | 0.16 |
실시예 5 | 0.17 | 0.18 | 0.19 |
실시예 6 | 0.17 | 0.16 | 0.17 |
실시예 7 | 0.19 | 0.18 | 0.17 |
실시예 8 | 0.11 | 0.10 | 0.11 |
비교예 1 | 0.93 | 0.92 | 0.93 |
비교예 2 | 0.82 | 0.82 | 0.83 |
비교예 3 | 0.84 | 0.83 | 0.84 |
비교예 4 | 0.86 | 0.85 | 0.79 |
비교예 5 | 0.87 | 0.86 | 0.81 |
비교예 6 | 0.85 | 0.84 | 0.91 |
비교예 7 | 0.85 | 0.85 | 0.83 |
칸디다 알비칸스 | 가드네렐라 바지날리스 | |
대조군 | 30 | 31 |
실시예 1 | 24 | 23 |
실시예 2 | 27 | 26 |
실시예 3 | 26 | 26 |
실시예 4 | 25 | 26 |
실시예 5 | 27 | 25 |
실시예 6 | 26 | 25 |
실시예 7 | 26 | 26 |
실시예 8 | 32 | 32 |
비교예 1 | - | - |
비교예 2 | 1 | 1 |
비교예 3 | 2 | 2 |
비교예 4 | 2 | 2 |
비교예 5 | 2 | 1 |
비교예 6 | 1 | 2 |
비교예 7 | 2 | 2 |
불쾌한 냄새 | 사용감 | 전체적인 기호도 | |
실시예 1 | 5 | 5 | 5 |
실시예 8 | 5 | 5 | 5 |
비교예 1 | 1 | 1 | 1 |
비교예 2 | 2 | 2 | 2 |
Claims (6)
- 티슈 원단 100 중량부에 대하여, 편백나무의 잎을 2 내지 5배 양(w/v)의 증류수를 넣고 1%(v/v)의 소금을 넣어 90℃~110℃에서 1 내지 2시간 동안 추출한 후 여과하여 수득된 편백 추출물 1 내지 40 중량부를 포함하며,
쑥 추출물, 모링가 추출물, 대나무 추출물, 병풀 추출물, 소나무 추출물 및 질경이 추출물을 티슈 원단 100 중량부에 대하여 1 내지 20 중량부의 양으로 포함하고,
쑥 추출물, 모링가 추출물, 대나무 추출물, 병풀 추출물, 소나무 추출물 및 질경이 추출물을 1:1:1:1:1:1 중량비로 혼합하여 첨가하는 것을 특징으로 하는 항아토피 및 항질염용 티슈. - 제 1 항에 있어서,
상기 티슈가 피부 짖무름 또는 가려움을 일으키지 않는 것을 특징으로 하는 항아토피 및 항질염용 티슈. - 삭제
- 제 1 항에 있어서,
상기 티슈는 건티슈 또는 물티슈인 것을 특징으로 하는 항아토피 및 항질염용 티슈. - 제 1 항에 있어서,
상기 질염이 칸디다성 질염 또는 세균성 질염인 것을 특징으로 하는 항아토피 및 항질염용 티슈. - 편백나무의 잎을 2 내지 5배 양(w/v)의 증류수를 넣고 1%(v/v)의 소금을 넣어 90℃~110℃에서 1 내지 2시간 동안 추출한 후 여과하여 편백 추출물을 수득하고,
티슈 원단 100 중량부에 대하여 편백 추출물을 1 내지 40 중량부의 양으로 혼합하며,
쑥 추출물, 모링가 추출물, 대나무 추출물, 병풀 추출물, 소나무 추출물 및 질경이 추출물을 티슈 원단 100 중량부에 대하여 1 내지 20 중량부의 양으로 포함하고,
쑥 추출물, 모링가 추출물, 대나무 추출물, 병풀 추출물, 소나무 추출물 및 질경이 추출물을 1:1:1:1:1:1 중량비로 혼합하여 첨가하는 것을 특징으로 하는 항아토피 및 항질염용 티슈의 제조방법.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190073045A KR102103021B1 (ko) | 2019-06-19 | 2019-06-19 | 편백 추출물을 함유하는 항아토피 및 항질염용 티슈 및 이의 제조방법 |
PCT/KR2020/006550 WO2020256288A1 (ko) | 2019-06-19 | 2020-05-19 | 편백 추출물을 함유하는 항아토피 및 항질염용 티슈 및 이의 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190073045A KR102103021B1 (ko) | 2019-06-19 | 2019-06-19 | 편백 추출물을 함유하는 항아토피 및 항질염용 티슈 및 이의 제조방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102103021B1 true KR102103021B1 (ko) | 2020-04-22 |
Family
ID=70472783
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190073045A Expired - Fee Related KR102103021B1 (ko) | 2019-06-19 | 2019-06-19 | 편백 추출물을 함유하는 항아토피 및 항질염용 티슈 및 이의 제조방법 |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR102103021B1 (ko) |
WO (1) | WO2020256288A1 (ko) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102178938B1 (ko) * | 2020-08-03 | 2020-11-16 | 박종호 | 질염 및 질건조증 예방 또는 치료용 조성물 |
KR102271989B1 (ko) | 2020-09-09 | 2021-07-02 | 주식회사 와일드원 | 편백 오일의 제조방법 및 이를 함유하는 항균 조성물 |
KR20220099176A (ko) * | 2021-01-05 | 2022-07-13 | (주)엔비바이오컴퍼니 | 천연물 복합 발효 추출물을 포함하는 항염증, 피부탄력 증진 효능을 갖는 조성물 |
KR102421212B1 (ko) * | 2021-07-13 | 2022-07-18 | 이승현 | 아토피 환자를 위한 피부자극이 저감된 의류 및 피부자극이 저감된 의류의 제조방법 |
KR20220108954A (ko) * | 2021-01-28 | 2022-08-04 | 계명대학교 산학협력단 | 편백나무 추출물, 자몽씨 추출물 및 발아현미 추출물을 유효성분으로 함유하는 천연복합방부제 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120041416A (ko) * | 2010-10-21 | 2012-05-02 | 전라남도 | 간수와 편백나무를 이용한 피부질환 개선제 제조법 |
KR101298423B1 (ko) * | 2011-12-27 | 2013-08-26 | 강현숙 | 화학적 방부제나 유화제를 사용하지 않고 편백 정유성분을 활용하여 식물성 항균 및 탈취기능성을 갖는 물티슈 |
KR20160015718A (ko) * | 2014-07-31 | 2016-02-15 | 이은선 | 쇠비름 추출물 및 피톤치드를 함유하는 여성 청결제 |
KR20190017585A (ko) * | 2017-08-11 | 2019-02-20 | (주) 피러스 | 침엽수 추출물을 이용한 기능성 물질을 포함하는 기능성 위생용품 및 그 제조방법 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120098117A (ko) * | 2011-02-28 | 2012-09-05 | 우인창 | 피톤치드 정유액을 포함하는 물티슈 및 그 제조 방법 |
-
2019
- 2019-06-19 KR KR1020190073045A patent/KR102103021B1/ko not_active Expired - Fee Related
-
2020
- 2020-05-19 WO PCT/KR2020/006550 patent/WO2020256288A1/ko active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120041416A (ko) * | 2010-10-21 | 2012-05-02 | 전라남도 | 간수와 편백나무를 이용한 피부질환 개선제 제조법 |
KR101298423B1 (ko) * | 2011-12-27 | 2013-08-26 | 강현숙 | 화학적 방부제나 유화제를 사용하지 않고 편백 정유성분을 활용하여 식물성 항균 및 탈취기능성을 갖는 물티슈 |
KR20160015718A (ko) * | 2014-07-31 | 2016-02-15 | 이은선 | 쇠비름 추출물 및 피톤치드를 함유하는 여성 청결제 |
KR20190017585A (ko) * | 2017-08-11 | 2019-02-20 | (주) 피러스 | 침엽수 추출물을 이용한 기능성 물질을 포함하는 기능성 위생용품 및 그 제조방법 |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102178938B1 (ko) * | 2020-08-03 | 2020-11-16 | 박종호 | 질염 및 질건조증 예방 또는 치료용 조성물 |
KR102296688B1 (ko) * | 2020-08-03 | 2021-08-31 | 박종호 | 천연물 유래의 질 건강 유지용 조성물 |
KR102271989B1 (ko) | 2020-09-09 | 2021-07-02 | 주식회사 와일드원 | 편백 오일의 제조방법 및 이를 함유하는 항균 조성물 |
KR20220099176A (ko) * | 2021-01-05 | 2022-07-13 | (주)엔비바이오컴퍼니 | 천연물 복합 발효 추출물을 포함하는 항염증, 피부탄력 증진 효능을 갖는 조성물 |
KR102501800B1 (ko) | 2021-01-05 | 2023-02-22 | (주)엔비바이오컴퍼니 | 천연물 복합 발효 추출물을 포함하는 항염증, 피부탄력 증진 효능을 갖는 조성물 |
KR20220108954A (ko) * | 2021-01-28 | 2022-08-04 | 계명대학교 산학협력단 | 편백나무 추출물, 자몽씨 추출물 및 발아현미 추출물을 유효성분으로 함유하는 천연복합방부제 |
KR102629656B1 (ko) | 2021-01-28 | 2024-01-29 | 계명대학교 산학협력단 | 편백나무 추출물, 자몽씨 추출물 및 발아현미 추출물을 유효성분으로 함유하는 천연복합방부제 |
KR102421212B1 (ko) * | 2021-07-13 | 2022-07-18 | 이승현 | 아토피 환자를 위한 피부자극이 저감된 의류 및 피부자극이 저감된 의류의 제조방법 |
Also Published As
Publication number | Publication date |
---|---|
WO2020256288A1 (ko) | 2020-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102103021B1 (ko) | 편백 추출물을 함유하는 항아토피 및 항질염용 티슈 및 이의 제조방법 | |
KR101345709B1 (ko) | 질염의 예방 또는 치료에 효과가 있는 항균제 조성물과 이를 포함하는 여성용 청결제 조성물 | |
KR102133101B1 (ko) | 백모화 및 쑥을 함유하는 여성청결제 조성물 | |
KR102033088B1 (ko) | 식물 추출 혼합물을 포함하는 항균, 항염, 항산화, 피지분비억제 및 피부염 개선용 조성물 | |
KR102518446B1 (ko) | 천연 원료 기반의 남성 청결제 | |
KR20160015718A (ko) | 쇠비름 추출물 및 피톤치드를 함유하는 여성 청결제 | |
CN109260054B (zh) | 一种植物防蚊止痒膏及其制备方法 | |
KR20080011847A (ko) | 천연 항균제 및 그 제조 방법 | |
KR102148808B1 (ko) | 천연 항균제를 포함하는 여성청결제 조성물 | |
KR101104898B1 (ko) | 강화사자발쑥 등의 한방 추출물을 함유하는 항균효과를 갖는 피부세정제 조성물 | |
RO128713B1 (ro) | Unguent pentru tratamentul arsurilor şi plăgilor, cu acţiune complexă, realizat exclusiv din produse naturale | |
KR100915711B1 (ko) | 보습, 항염증, 항세균 또는 항알레르기용 조성물 및 그의 제조방법 | |
KR101924822B1 (ko) | 렌틸콩 추출물을 포함하는 여성 청결제 조성물 | |
KR101168225B1 (ko) | 복합 생약 발효 추출물 및 이를 함유하는 여성용 청결제 조성물 | |
KR101587446B1 (ko) | 아임계추출조건으로 추출한 추출물 il-s를 포함하는 항균, 보습, 가려움개선, 세라마이드증가, 항염 효과를 지닌 화장료 조성물 | |
KR20190092038A (ko) | 자귀나무 수피 추출물을 유효성분으로 함유하는 항균 활성을 가지는 조성물 및 이를 포함하는 여성청결제 조성물 | |
KR102172448B1 (ko) | 동백유박 추출물을 유효성분으로 함유하는 항균 활성을 가지는 조성물 및 이를 포함하는 여성청결제 조성물 | |
KR20100130877A (ko) | 피부 염증 및 자극 완화 효과를 갖는 조성물 | |
CN106924657A (zh) | 一种用于治疗老年性阴道炎的植物精油组合物及制备方法、应用 | |
WO2008055107A2 (en) | Use of cotinus coggygria extract treating hemorrhoids | |
KR101594034B1 (ko) | 덤불쑥, 알꽈리 및 동백나무잎 복합추출물을 함유하는 항피부알러지, 항염증및 노인성 체취 제거용 조성물 | |
CN100455307C (zh) | 一种治疗皮肤病的外用药 | |
CN116322729A (zh) | 富含多糖的肋果木棉花提取物 | |
KR20100023162A (ko) | 위생 용품 | |
Sewwandi et al. | Literature review on selected Ayurvedic formula in the management of wound healing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20190619 |
|
PA0201 | Request for examination | ||
PA0302 | Request for accelerated examination |
Patent event date: 20190910 Patent event code: PA03022R01D Comment text: Request for Accelerated Examination Patent event date: 20190619 Patent event code: PA03021R01I Comment text: Patent Application |
|
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20191118 Patent event code: PE09021S01D |
|
E90F | Notification of reason for final refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Final Notice of Reason for Refusal Patent event date: 20200330 Patent event code: PE09021S02D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20200413 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20200414 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20200416 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20240125 |